AI-Powered ECG Analysis Shows Promise in Detecting Cognitive Decline
A new study reveals that artificial intelligence analysis of ECG data could potentially identify premature aging and cognitive decline, offering a novel approach to early detection of age-related cognitive issues using widely available medical technology.
A preliminary study presented at the upcoming American Stroke Association's International Stroke Conference 2025 suggests that artificial intelligence analysis of electrocardiogram (ECG) data could serve as an early warning system for cognitive decline and premature aging.
Researchers at UMass Chan Medical School analyzed data from over 63,000 UK Biobank participants, finding that individuals whose AI-predicted biological age exceeded their chronological age performed worse on cognitive tests compared to those with normal or decelerated aging patterns.
The implications of this research could be far-reaching for healthcare. If validated, the approach could provide a cost-effective and widely accessible method for screening cognitive decline, particularly valuable in rural areas or regions lacking specialized neuropsychiatric care. The study suggests that routine ECG tests, already common in medical practices, could serve a dual purpose in monitoring both heart and brain health.
Lead author Bernard Ofosuhene emphasized that ECG-age reflects the functional status of the heart and potentially the entire organism at the tissue level, offering insights beyond traditional chronological age measurements. The study found that participants with accelerated ECG-aging performed worse on six out of eight cognitive tests compared to those with normal aging patterns.
While the research shows promise, several limitations exist. The study's findings are preliminary and haven't undergone peer review. Additionally, the research focused on a predominantly European ancestry population between ages 43 and 85, raising questions about its applicability to other demographic groups.
The potential impact on healthcare delivery could be significant, as ECG data collected through routine medical visits or wearable devices might offer an objective, efficient method for cognitive assessment. This could lead to earlier interventions and more targeted treatment approaches for age-related cognitive decline.